p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1530-0285
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial ; day:25 ; month:6 ; year:2022 ; pages:1-9
Modern pathology ; (25.6.2022), 1-9
- Creator
-
Vermij, Lisa
Léon-Castillo, Alicia
Singh, Naveena
Powell, Melanie E.
Edmondson, Richard J.
Genestie, Catherine
Khaw, Pearly
Pyman, Jan
McLachlin, C. Meg
Ghatage, Prafull
Boer, Stephanie M. de
Nijman, Hans W.
Smit, Vincent T. H. B. M.
Crosbie, Emma J.
Leary, Alexandra
Creutzberg, Carien L.
Horeweg, Nanda
Bosse, Tjalling
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41379-022-01102-x
- URN
-
urn:nbn:de:101:1-2022081819115044799713
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vermij, Lisa
- Léon-Castillo, Alicia
- Singh, Naveena
- Powell, Melanie E.
- Edmondson, Richard J.
- Genestie, Catherine
- Khaw, Pearly
- Pyman, Jan
- McLachlin, C. Meg
- Ghatage, Prafull
- Boer, Stephanie M. de
- Nijman, Hans W.
- Smit, Vincent T. H. B. M.
- Crosbie, Emma J.
- Leary, Alexandra
- Creutzberg, Carien L.
- Horeweg, Nanda
- Bosse, Tjalling
- SpringerLink (Online service)
Other Objects (12)
Quality control in molecular immunohistochemistry
p53 immunohistochemistry discriminates between pure erythroid leukemia and reactive erythroid hyperplasia
Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans
Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
Metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis
Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry
Pathophysiology of primary aldosteronism: adrenal immunohistochemistry and molecular profiling studies
Cell and molecular biology of endometrial carcinoma
MicroRNAs, endometrial receptivity and molecular pathways
Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry
Analysis of the Molecular Profile of Melanoma Brain Metastases using Immunohistochemistry
Quality control in molecular immunohistochemistry
p53 immunohistochemistry discriminates between pure erythroid leukemia and reactive erythroid hyperplasia
Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans
Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
Metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis
Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry
Pathophysiology of primary aldosteronism: adrenal immunohistochemistry and molecular profiling studies
Cell and molecular biology of endometrial carcinoma
MicroRNAs, endometrial receptivity and molecular pathways
Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry
Analysis of the Molecular Profile of Melanoma Brain Metastases using Immunohistochemistry
Quality control in molecular immunohistochemistry
p53 immunohistochemistry discriminates between pure erythroid leukemia and reactive erythroid hyperplasia
Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans
Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
Metanephric adenosarcoma: a rare case with immunohistochemistry and molecular analysis
Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry
Pathophysiology of primary aldosteronism: adrenal immunohistochemistry and molecular profiling studies
Cell and molecular biology of endometrial carcinoma
MicroRNAs, endometrial receptivity and molecular pathways
Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry